Showing results (681-690 of 1,988) with videos related to

Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|May 4, 2023
15-year biochemical failure, metastasis, salvage therapy, and cancer-specific and overall survival rates in men treated with robotic radical prostatectomy for PSA-screen detected prostate cancerAkshay Sood, Ralph Grauer, Mireya Diaz-Insua, et al.
Prostate Cancer and Prostatic Diseases|March 31, 2023
Perceived patient burden and acceptability of MRI in comparison to PSA and ultrasound: results from the IP1-PROSTAGRAM studyDavid Eldred-Evans, Mathias Winkler, Natalia Klimowska-Nassar, et al.
Prostate Cancer and Prostatic Diseases|December 10, 2003
A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasiaP Rigatti, M Brausi, R M Scarpa, et al.
Prostate Cancer and Prostatic Diseases|December 10, 2003
Immune function, mitogenicity, and angiogenic growth factor concentrations in lean and obese rodent sera: implications in obesity-related prostate tumor biologyJ H Mydlo, M I Gerstein, C F Harris, et al.
Prostate Cancer and Prostatic Diseases|December 10, 2003
Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot studyB W Guess, M C Scholz, S B Strum, et al.
Prostate Cancer and Prostatic Diseases|December 10, 2003
Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective studyH Ozveri, I Cevik, O Dillioglugil, et al.
Prostate Cancer and Prostatic Diseases|July 6, 2019
Cost-effectiveness analysis of Abiraterone Acetate versus Docetaxel in the management of metastatic castration-sensitive prostate cancer: Hong Kong's perspectiveChi Leung Chiang, Tsz Him So, Tai Chung Lam, et al.
Prostate Cancer and Prostatic Diseases|June 28, 2019
Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapyDaniel J Canter, Stephen Freedland, Saradha Rajamani, et al.
Prostate Cancer and Prostatic Diseases|October 16, 2019
A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancerAshley E Ross, Paula J Hurley, Phuoc T Tran, et al.
Prostate Cancer and Prostatic Diseases|April 14, 2019
Dietary inflammatory index (DII) and risk of prostate cancer in a case-control study among Black and White US Veteran menAdriana C Vidal, Taofik Oyekunle, Lauren E Howard, et al.
Pageof 199